Centre for Nanotechnology & Regenerative Medicine, UCL Division of Surgery & Interventional Sciences, University College London, London, UK.
Acta Biomater. 2010 Nov;6(11):4249-60. doi: 10.1016/j.actbio.2010.06.015. Epub 2010 Jun 18.
Calcification currently represents a major cause of failure of biological tissue heart valves. It is a complex phenomenon influenced by a number of biochemical and mechanical factors. Recent advances in material science offer new polymers with improved properties, potentially suitable for synthetic leaflets heart valves manufacturing. In this study, the calcification-resistance efficacy and mechanical and surface properties of a new nanocomposite polymeric material (polyhedral oligomeric silsesquioxane-poly(carbonate-urea)urethane; POSS-PCU) which has been developed by our group are assessed by means of in vitro testing. In particular, thin sheets of nanocomposite, glutaraldehyde-fixed bovine pericardium (BP) and polyurethane (PU) were exposed to a calcium solution into a specially designed in vitro accelerated physiological pulsatile pressure system for a period of 31days and a total of 4×10(7) cycles. The samples were investigated for signs of calcification after exposure to calcium solution by means of X-ray, microscopic and chemical inspections. Mechanical and surface properties were also studied using stress-strain behaviour and surface morphology and hydrophobicity. Comparison shows that, in the experimental conditions, the level of calcification for the nanocomposite is considerably lower than for the fixed BP (p=0.008) and PU samples (p=0.015). Also, mechanical properties were unchanged in POSS-PCU, while there was a significant deterioration in PU samples (p<0.05). Hydrophobicity was significantly reduced in both the POSS-PCU and PU samples (p<0.0001). However, the POSS-PCU nanocomposite remained more hydrophobic than the PU sample (p<0.0001). Less platelet adhered to the POSS-PCU compared to the PU (p<0.0001). These results indicate that the use of this nanocomposite in synthetic leaflets heart valves may lead to potential advantages in terms of long-term performances and durability.
目前,钙化是生物组织心脏瓣膜失效的主要原因。它是一个受多种生化和机械因素影响的复杂现象。材料科学的最新进展提供了具有改进性能的新型聚合物,这些聚合物可能适用于合成瓣叶心脏瓣膜的制造。在这项研究中,通过体外测试评估了我们小组开发的新型纳米复合聚合物材料(多面体低聚倍半硅氧烷-聚(碳酸酯-脲)聚氨酯;POSS-PCU)的抗钙化效果以及机械和表面性能。具体来说,将纳米复合材料薄片、戊二醛固定的牛心包(BP)和聚氨酯(PU)暴露于钙溶液中,置于专门设计的体外加速生理脉动压力系统中 31 天,总共进行 4×10(7)次循环。通过 X 射线、显微镜和化学检查,在暴露于钙溶液后,检查样品的钙化迹象。还使用应力-应变行为以及表面形态和疏水性研究了机械和表面性能。比较表明,在实验条件下,纳米复合材料的钙化水平明显低于固定 BP(p=0.008)和 PU 样品(p=0.015)。此外,POSS-PCU 的机械性能保持不变,而 PU 样品的机械性能显著恶化(p<0.05)。POSS-PCU 和 PU 样品的疏水性均显著降低(p<0.0001)。然而,POSS-PCU 纳米复合材料比 PU 样品更疏水(p<0.0001)。与 PU 相比,更少的血小板黏附在 POSS-PCU 上(p<0.0001)。这些结果表明,在合成瓣叶心脏瓣膜中使用这种纳米复合材料可能在长期性能和耐久性方面具有潜在优势。